Letko, Brosseau & Associates’s TScan Therapeutics TCRX Stock Holding History

Letko, Brosseau & Associates’s Portfolio TCRX Stock Details TCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$139K	Buy
2025 Q1	$106K	Buy
2024 Q4	$110K	Buy
2024 Q3	$103K	Hold
2024 Q2	$121K	Hold
2024 Q1	$164K	Hold
2023 Q4	$121K	Sell
2023 Q3	$82.9K	Buy